The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Book
This manual is divided into four distinct units, which include: Materials Management Organization and Administration, Materials Management Functional…
On-Demand Educational Webinars
Reducing variability in products, supplies, pharmaceuticals, and other cost drivers is key to achieving margins in Medicare payment. This webinar…
On-Demand Educational Webinars
Social responsibility is an emerging area of importance for all health care supply chain professionals to understand and participate in. This webinar…
Podcasts
Hear one provider’s ongoing process of UDI implementation, from deciphering acronyms and educating interdepartmental staff, to working with vendors
Podcasts
In this three-part podcast, Howard Mann, Vice President, Supply Chain Management at Cardiovascular Care Group discusses the basics and relationship
Podcasts
Learn about how the significant number of clinical alarms have a numbing effect on nursing staff, to the point that patient safety is in jeopardy.